{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:54:23Z","timestamp":1791356063595,"version":"4.3.1"},"reference-count":146,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":2559,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas (English Edition)"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.adengl.2013.01.001","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T03:00:45Z","timestamp":1374634845000},"page":"598-616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Guidelines for the Use of Acitretin in Psoriasis"],"prefix":"10.1016","volume":"104","author":[{"given":"G.","family":"Carretero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ribera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Belinch\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Carrascosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ll.","family":"Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ferrandiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Dehesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Peral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Jorquera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gonzalez-Quesada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Notario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Vanaclocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adengl.2013.01.001_bib0005","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.annder.2011.10.001","article-title":"Acitretin","volume":"138","author":"Dubertret","year":"2011","journal-title":"Ann. Dermatol. Venereol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0010","first-page":"772","article-title":"Acitretin in dermatology: A review","volume":"10","author":"Dunn","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.adengl.2013.01.001_bib0015","first-page":"1","article-title":"Acitretin revisited","volume":"16","author":"Lynde","year":"2011","journal-title":"Skin Therapy Lett"},{"key":"10.1016\/j.adengl.2013.01.001_bib0020","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/09546630903578582","article-title":"Acitretin revisited in the era of biologics","volume":"22","author":"Booij","year":"2011","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.adengl.2013.01.001_bib0025","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/j.1365-2133.2010.09755.x","article-title":"British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology","volume":"162","author":"Ormerod","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0030","first-page":"593","article-title":"Retinoids: Biological function and use in the treatment of dermatological diseases. Expert opinion investigational","volume":"4","author":"Boehm","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.adengl.2013.01.001_bib0035","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1677\/joe.0.1460201","article-title":"Retinoids: Transport, metabolism and mechanism of action","volume":"146","author":"Vieira","year":"1995","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0040","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2174\/1381612003400146","article-title":"Recent developments in receptor-selective retinoids","volume":"6","author":"Nagpal","year":"2000","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.adengl.2013.01.001_bib0045","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1529-8019.2006.00082.x","article-title":"Update on retinoid therapy of psoriasis in: an update on the use of retinoids in dermatology","volume":"19","author":"Van de Kerkhof","year":"2006","journal-title":"Dermatol Ther"},{"issue":"Suppl 3","key":"10.1016\/j.adengl.2013.01.001_bib0050","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/S0151-9638(10)70036-3","article-title":"Retinoids: Mechanisms of action","volume":"137","author":"Berbis","year":"2010","journal-title":"Ann. Dermatol. Venereol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0055","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0213-9251(05)72228-0","article-title":"Biolog\u00eda de los receptores de los retinoides","volume":"20","author":"Soria","year":"2005","journal-title":"Piel"},{"key":"10.1016\/j.adengl.2013.01.001_bib0060","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1016\/S0190-9622(98)70308-1","article-title":"Rational design of receptor-selective retinoids","volume":"39","author":"Chandraratna","year":"1998","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0065","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0014-2964(74)90112-1","article-title":"Therapeutic effects of an aromatic acid analog on chemically induced skin papilomas and carcinomas of mice","volume":"10","author":"Bollag","year":"1974","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.adengl.2013.01.001_bib0070","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0140-6736(83)91394-6","article-title":"Vitamin A and retinoids, from nutrition to pharmacotherapy in dermatology and oncology","volume":"1","author":"Bollag","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.adengl.2013.01.001_bib0075","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0012-1606(89)90037-7","article-title":"Retinoic acid improves epidermal morphogenesis","volume":"133","author":"Asselineau","year":"1989","journal-title":"Dev. Biol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0080","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0738-081X(97)00013-8","article-title":"Retinoids","volume":"15","author":"Gollnick","year":"1997","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0085","first-page":"47","article-title":"Advances in psoriasis therapy","volume":"12","author":"Koo","year":"1997","journal-title":"Adv. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0090","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1600-0560.2007.00800.x","article-title":"Comparative study of histopathological and immunohistochemical findings in skin biopsies from patients with psoriasis before and after treatment with acitretin","volume":"35","author":"Werner","year":"2008","journal-title":"J Cut Pathol"},{"key":"10.1016\/j.adengl.2013.01.001_bib0095","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1600-0560.1996.tb01430.x","article-title":"Cellular actions of etretinate in psoriasis: Enhanced epidermal differentiation and reduced cell-mediated inflammation are unexpected outcomes","volume":"23","author":"Gottlieb","year":"1996","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1346-8138.2012.01637.x","article-title":"Acitretin exerted a greater influence on T-helper (Th)1 and Th17 than on Th2 cells in treatment of psoriasis vulgaris","volume":"39","author":"Niu","year":"2012","journal-title":"J. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0105","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1517\/14656566.6.10.1725","article-title":"A review of acitretin, a systemic retinoid for the treatment of psoriasis","volume":"6","author":"Lee","year":"2005","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.adengl.2013.01.001_bib0110","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0733-8635(03)00126-8","article-title":"Retinoid therapy for psoriasis","volume":"22","author":"Yamauchi","year":"2004","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.adengl.2013.01.001_bib0115","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000250839","article-title":"Severe psoriasis\u2013oral therapy with a new retinoid","volume":"157","author":"Fredriksson","year":"1978","journal-title":"Dermatologica"},{"key":"10.1016\/j.adengl.2013.01.001_bib0120","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0014-4827(88)90396-5","article-title":"Specificity in the synergism between retinoic acid and EFG on the growth of adult human skin fibroblasts","volume":"178","author":"Harper","year":"1988","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.adengl.2013.01.001_bib0125","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/1523-1747.ep12284027","article-title":"Synthetic retinoids inhibit the antigen-presenting properties of epidermal cells in vivo","volume":"93","author":"Dupuy","year":"1989","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0130","series-title":"Retinoid therapy: A review of clinical and laboratory research","first-page":"101","article-title":"Effects of synthetic retinoids on human peripheral blood lymphocytes and polimorphonuclears in vivo","author":"Bauer","year":"1984"},{"key":"10.1016\/j.adengl.2013.01.001_bib0135","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0304-4165(95)00179-4","article-title":"Characterization of synthetic retinoids with selectivity for retinoic acid or retinoid X nuclear receptors","volume":"1289","author":"LeMotte","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.adengl.2013.01.001_bib0140","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/scel.1994.1015","article-title":"The retinoid signaling pathway: Molecular and genetic analysis","volume":"5","author":"Chambon","year":"1994","journal-title":"Semin. Cell Biol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0145","first-page":"2","article-title":"The molecular mechanism of retinoid action. Retinoids today and tomorrow","volume":"44","author":"Pfhal","year":"1996","journal-title":"Retinoid Dermatol"},{"key":"10.1016\/j.adengl.2013.01.001_bib0150","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1074\/jbc.275.1.642","article-title":"Regulation of vascular endothelial growth factor expression in human keratinocytes by retinoids","volume":"275","author":"Diaz","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.adengl.2013.01.001_bib0155","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0190-9622(99)70358-0","article-title":"Retinoids and psoriasis: Novel issues in retinoid pharmacology and implications for psoriasis treatment","volume":"41","author":"Saurat","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"issue":"98 Suppl","key":"10.1016\/j.adengl.2013.01.001_bib0160","doi-asserted-by":"crossref","first-page":"36S","DOI":"10.1111\/1523-1747.ep12462180","article-title":"Retinoic acid receptors and binding proteins in human skin","author":"Elder","year":"1992","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0165","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1145697","article-title":"Reciprocal TH17 and regulatory T-cell differentiation mediated by retinoic acid","volume":"317","author":"Mucida","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.adengl.2013.01.001_bib0170","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0190-9622(89)70236-X","article-title":"A double-blind, placebo controlled trial of acitretin for the treatment of psoriasis","volume":"21","author":"Olsen","year":"1989","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0175","first-page":"104","article-title":"Acitretin treatment of severe psoriasis","volume":"146","author":"Torok","year":"1989","journal-title":"Acta Dermatol Venereol Suppl (Stockh)"},{"key":"10.1016\/j.adengl.2013.01.001_bib0180","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/0190-9622(91)70091-F","article-title":"A 12-month treatment of severe psoriasis with acitretin: Results of a Canadian open multicentre trial","volume":"24","author":"Murray","year":"1991","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0185","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/sj.jid.5700096","article-title":"Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis","volume":"126","author":"Young","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0190","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/00003495-199243040-00010","article-title":"Acitretin: A review of its pharmacology and therapeutic use","volume":"43","author":"Pilkigton","year":"1992","journal-title":"Drugs"},{"key":"10.1016\/j.adengl.2013.01.001_bib0195","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/j.1552-4604.1988.tb03129.x","article-title":"Food increases the bioavailability of acitretin","volume":"28","author":"McNamara","year":"1988","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0200","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/0006-2952(92)90087-Y","article-title":"Comparative binding of etretinate and acitretin to plasma proteins and erythrocytes","volume":"44","author":"Urien","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0205","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0733-8635(05)70016-4","article-title":"Systemic retinoids: What's new","volume":"16","author":"Saurat","year":"1998","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.adengl.2013.01.001_bib0210","doi-asserted-by":"crossref","first-page":"PL 169","DOI":"10.1016\/0024-3205(91)90332-6","article-title":"A newly discovered xenobiotic metabolic pathway: Ethyl ester formation","volume":"49","author":"Chou","year":"1991","journal-title":"Life Sci."},{"key":"10.1016\/j.adengl.2013.01.001_bib0215","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0006-2952(00)00339-7","article-title":"In vitro metabolism of acitretin by human liver microsomes: evidence of an acitretinoyl-coenzyme A thioester conjugate in the transesterification to etretinate","volume":"60","author":"Knights","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0220","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2133.1993.tb00145.x","article-title":"Effect of etretinete on cyclosporin metabolism in vitro","volume":"128","author":"Webber","year":"1993","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0225","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0190-9622(88)70198-X","article-title":"Acitretin versus etretinate in psoriasis. Clinical and pharmacokinetic results of a German multicenter study","volume":"19","author":"Gollnick","year":"1988","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0230","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/j.1552-4604.1991.tb01907.x","article-title":"The pharmacokinetics of acitretin and its 13-cis-metabolite in psoriatic patients","volume":"31","author":"Larsen","year":"1991","journal-title":"Clin Pharmacol"},{"key":"10.1016\/j.adengl.2013.01.001_bib0235","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/S0190-9622(98)70441-4","article-title":"Pharmacokinetics of acitren and etretinate","volume":"39","author":"Wiegand","year":"1998","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0240","first-page":"487","article-title":"Acitretin excretion into human breast milk","volume":"70","author":"Rollman","year":"1990","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0245","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000313331","article-title":"Retinoid Pathway and congenital diaphragmatic hernia: Hypothesis from the analysis of chromosomal abnormalities","volume":"28","author":"Goumy","year":"2010","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/j.adengl.2013.01.001_bib0250","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1346-8138.1999.tb03444.x","article-title":"Treatments of generalized pustular psoriasis: A multicenter study in Japan","volume":"26","author":"Ozawa","year":"1999","journal-title":"J. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0255","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1517\/14740330903393732","article-title":"A review of acitretin for the treatment of psoriasis","volume":"8","author":"Lee","year":"2009","journal-title":"Expert Opin Drug Saf"},{"issue":"Suppl 2","key":"10.1016\/j.adengl.2013.01.001_bib0260","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1468-3083.2011.03993.x","article-title":"Efficacy and safety of oral retinoids in different psoriasis subtypes: A systematic literature review","volume":"25","author":"Sbidian","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"Suppl 2","key":"10.1016\/j.adengl.2013.01.001_bib0265","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1468-3083.2011.03990.x","article-title":"Evidence-based recommendations on conventional systemic treatments in psoriasis: systematic review and expert opinion of a panel of dermatologists","volume":"25","author":"Paul","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0270","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2133.1987.tb04140.x","article-title":"Treatment of severe psoriasis with etretin (RO 10-1670)","volume":"117","author":"Lassus","year":"1987","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0275","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0190-9622(83)70203-3","article-title":"Etretinate in severe psoriasis: results of double-blind study and maintenance therapy in pustular psoriasis","volume":"9","author":"Wolska","year":"1983","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0280","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000248701","article-title":"Acitretin (Ro 10-1670, etretin): overall evaluation of clinical studies","volume":"176","author":"Geiger","year":"1988","journal-title":"Dermatologica"},{"key":"10.1016\/j.adengl.2013.01.001_bib0285","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/archderm.1997.03890420043005","article-title":"Acitretin therapy is effective for psoriasis associated with human immunodeficiency virus infection","volume":"133","author":"Buccheri","year":"1997","journal-title":"Arch. Dermatol."},{"issue":"1 Suppl 1","key":"10.1016\/j.adengl.2013.01.001_bib0290","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaad.2009.03.017","article-title":"A series of critically challenging case scenarios in moderate to severe psoriasis: A Delphi consensus approach","volume":"61","author":"Strober","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"issue":"Suppl 2","key":"10.1016\/j.adengl.2013.01.001_bib0295","first-page":"5","article-title":"European S3-Guidelines on the systemic treatment of psoriasis vulgaris","volume":"23","author":"Pathirana","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"Suppl 49","key":"10.1016\/j.adengl.2013.01.001_bib0300","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2133.1996.tb15661.x","article-title":"Oral retinoids\u2014efficacy and toxicity in psoriasis","volume":"135","author":"Gollnick","year":"1996","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0305","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0190-9622(99)70360-9","article-title":"Acitretin: Optimal dosing strategies","volume":"41","author":"Ling","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0310","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0190-9622(88)70086-9","article-title":"Acitretin improves psoriasis in a dose-dependent fashion","volume":"18","author":"Goldfarb","year":"1988","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0315","article-title":"Efficacy and safety of acitretin in three fixed doses of 25, 35 and 50mg in adult patients with severe plaque type psoriasis: A randomized, double blind, parallel group, dose ranging study","author":"Dogra","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0320","first-page":"86","article-title":"Efficacy of low-dose acitretin in the treatment of psoriasis","volume":"2","author":"Haushalter","year":"2011","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.adengl.2013.01.001_bib0325","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/archderm.142.8.1000","article-title":"Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasis","volume":"142","author":"Pearce","year":"2006","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0330","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2133.2005.06563.x","article-title":"Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks","volume":"152","author":"Naldi","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0335","first-page":"35","article-title":"A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis: Results of a Nordic multicentre study","volume":"69","author":"Kragballe","year":"1989","journal-title":"Acta Dermatol Venereol"},{"key":"10.1016\/j.adengl.2013.01.001_bib0340","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000248398","article-title":"Benefit of progressively increasing doses during the initial treatment with acitretin in psoriasis","volume":"178","author":"Berbis","year":"1989","journal-title":"Dermatologica"},{"key":"10.1016\/j.adengl.2013.01.001_bib0345","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jaad.2009.03.027","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents","volume":"61","author":"Menter","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0350","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1365-2133.1998.02030.x","article-title":"The effect of addition of calcipotriol ointment (50 micrograms\/g) to acitretin therapy in psoriasis","volume":"138","author":"Van de Kerkhof","year":"1998","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0355","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jaad.2011.01.032","article-title":"Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis Foundation","volume":"67","author":"Robinson","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0360","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1365-2133.1988.tb03499.x","article-title":"Acitretin and etretinate in the treatment of palmoplantar pustulosis. A double-blind comparative trial","volume":"119","author":"Lassus","year":"1988","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0365","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/archdermatol.2008.600","article-title":"Evaluation of the efficacy of acitretin therapy for nail psoriasis","volume":"145","author":"Tosti","year":"2009","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0370","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1590\/S0365-05962012000200010","article-title":"NAPSI utilization as an evaluation method of nail psoriasis in patients using acitretin","volume":"87","author":"Mukai","year":"2012","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0375","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2133.2005.06906.x","article-title":"Oral retinoids therapy for disorders of keratinization: A single-centre retrospective 25 years\u2019 experience on 23 patients","volume":"154","author":"Katugampola","year":"2006","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0380","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0190-9622(99)70359-2","article-title":"Acitretin in psoriasis: An overview of adverse effects","volume":"41","author":"Katz","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0385","first-page":"1921","article-title":"Side effects of oral retinoid Ro 10-9359 on the unaffected skin of psoriatic patients: Retinoid dermatitis","volume":"109","author":"R\u00fcst","year":"1979","journal-title":"Schweiz. Med. Wochenschr."},{"key":"10.1016\/j.adengl.2013.01.001_bib0390","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1440-0960.2009.00542.x","article-title":"Repigmentation and curling of hair after acitretin therapy","volume":"50","author":"Seckin","year":"2009","journal-title":"Australas. J. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0395","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0168-8278(90)90111-4","article-title":"Severe hepatotoxic reaction with progression to cirrhosis after use of a novel retinoid (acitretin)","volume":"11","author":"Van Dizhuijsen","year":"1990","journal-title":"J. Hepatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0400","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bbalip.2011.06.023","article-title":"Hepatic metabolism of retinoids and disease associations","volume":"1821","author":"Shirakami","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.adengl.2013.01.001_bib0405","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0190-9622(99)70359-2","article-title":"Acitretin in psoriasis: An overview of adverse effects","volume":"41","author":"Ratz","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0410","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S0190-9622(89)70138-9","article-title":"Side-effect profile of acitretin therapy in psoriasis","volume":"20","author":"Gupta","year":"1989","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0415","first-page":"690","article-title":"Evidence based or theoretical concern? Pseudotumor cerebri and depression as acitretin side effects","volume":"4","author":"Starling","year":"2005","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.adengl.2013.01.001_bib0420","first-page":"306","article-title":"Pseudotumor cerebro induced by vitamin A combined with minocycline","volume":"25","author":"Moskowitz","year":"1993","journal-title":"Ann. Ophthalmol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0425","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1159\/000248881","article-title":"Skeletal changes associated with chronic isotretinoin and etretinate administration","volume":"175","author":"McGuire","year":"1987","journal-title":"Dermatologica"},{"key":"10.1016\/j.adengl.2013.01.001_bib0430","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-2133.1996.d01-742.x","article-title":"Prolonged treatment with oral retinoids in adults: No influence on the frequency and severity of spinal abnormalities","volume":"134","author":"van Dooren-Greebe","year":"1996","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0435","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/archdermatol.2010.59","article-title":"High-dose treatment with vitamin A analogues and risk of fractures","volume":"146","author":"Vestergaard","year":"2010","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0440","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1365-2230.2003.01265.x","article-title":"Association between long-term acitretin therapy and osteoporosis: No evidence of increased risk","volume":"28","author":"McMullen","year":"2003","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0445","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1521-6926(03)00043-4","article-title":"Retinoic acid syndrome: manifestations, pathogenesis, and treatment","volume":"16","author":"Larson","year":"2003","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0450","doi-asserted-by":"crossref","first-page":"292","DOI":"10.7326\/0003-4819-117-4-292","article-title":"The \u201cretinoic acid syndrome\u201d in acute promyelocytic leukemia","volume":"117","author":"Frankel","year":"1992","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.adengl.2013.01.001_bib0455","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5070\/D36XW860XK","article-title":"Respiratory disress with acitretin, reversal by corticosteroid","volume":"7","author":"Cuhadaroglu","year":"2001","journal-title":"Dermatol. Online J."},{"key":"10.1016\/j.adengl.2013.01.001_bib0460","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1016\/j.jaad.2011.05.009","article-title":"Acitretin-induced retinoic acid syndrome","volume":"65","author":"Gu","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0465","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1684\/ejd.2009.0761","article-title":"Retinoic acid syndrome in a patient with psoriasis","volume":"19","author":"Liu","year":"2009","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0470","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJM198510033131401","article-title":"Retinoic acid embryopathy","volume":"313","author":"Lammer","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.adengl.2013.01.001_bib0475","first-page":"273","article-title":"Adverse effects of retinoids","volume":"3","author":"David","year":"1988","journal-title":"Med. Toxicol. Adverse Drug Exp."},{"key":"10.1016\/j.adengl.2013.01.001_bib0480","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2133.1997.tb14946.x","article-title":"Etretinate may work where acitretin fails","volume":"136","author":"Bleiker","year":"1997","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0485","first-page":"409","article-title":"Depression and acitretin: a true association or a class labeling?","volume":"10","author":"Hayes","year":"2011","journal-title":"J Drugs Dermatol"},{"issue":"Suppl","key":"10.1016\/j.adengl.2013.01.001_bib0490","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S0190-9622(08)80257-5","article-title":"Long-term safety of retinoid therapy","volume":"27","author":"Vahlquist","year":"1992","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0495","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archdermatol.2009.5","article-title":"Efficacy and safety of combination Acitretin and Pioglitazone therapy in patients with moderate to severe chronic plaque-type psoriasis: A randomized, double-blind, placebo-controlled clinical trial","volume":"145","author":"Mittal","year":"2009","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0500","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2133.2005.06369.x","article-title":"Pioglitazone: A promising therapy for psoriasis","volume":"152","author":"Robertshaw","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0505","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0190-9622(99)80058-9","article-title":"Effects of acitretin on the liver","volume":"41","author":"Roenigk","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0510","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/BF00426620","article-title":"Acitretin (RO 10-1670) and oral contraceptives: interaction study","volume":"280","author":"Berbis","year":"1988","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.adengl.2013.01.001_bib0515","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJM199105163242002","article-title":"Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)","volume":"324","author":"Warrell","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.adengl.2013.01.001_bib0520","doi-asserted-by":"crossref","first-page":"1417S","DOI":"10.1093\/ajcn\/62.6.1417S","article-title":"Prevention of cervical intraepithelial neoplasia and cervical cancer","volume":"62","author":"Meyskens","year":"1995","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.adengl.2013.01.001_bib0525","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/S0190-9622(98)70451-7","article-title":"Retinoid chemoprevention in the high-risk patient","volume":"39","author":"DiGiovanna","year":"1998","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0530","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mrfmmm.2004.05.020","article-title":"Signaling pathways in retinoid chemoprevention and treatment of cancer","volume":"555","author":"Niles","year":"2004","journal-title":"Mutat. Res."},{"key":"10.1016\/j.adengl.2013.01.001_bib0535","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000082093","article-title":"Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. Updated analysis of the long-term follow-up data","volume":"48","author":"Takai","year":"2005","journal-title":"Intervirology"},{"key":"10.1016\/j.adengl.2013.01.001_bib0540","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3109\/01443610903177128","article-title":"Pregnancy outcome of women transfused during pregnancy with blood products inadvertently obtained from donors treated with acitretin","volume":"29","author":"Han","year":"2009","journal-title":"J. Obstet. Gynaecol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0545","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1468-3083.2006.01573.x","article-title":"Effects of acitretin on spermatogenesis of rats","volume":"20","author":"Sengor","year":"2006","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0550","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000063893","article-title":"Is there a reproductive safety risk in male patients treated with acitretin (neotigason\/soriatane)?","volume":"205","author":"Geiger","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.adengl.2013.01.001_bib0555","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaad.2011.07.039","article-title":"Review of treatment options for psoriasis in pregnant or lactating women: From the Medical Board of the National Psoriasis Foundation","volume":"67","author":"Bae","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0560","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jaad.2002.12.002","article-title":"Combination therapy to treat moderate to severe psoriasis","volume":"50","author":"Lebwohl","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0565","first-page":"94","article-title":"Combination therapy in the treatment of psoriasis","volume":"9","author":"Domm","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.adengl.2013.01.001_bib0570","first-page":"873","article-title":"Acitretin for the treatment of psoriasis: an assessment of national trends","volume":"10","author":"Ghasri","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.adengl.2013.01.001_bib0575","first-page":"S62","article-title":"Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: Review of the literature and results of a survey sent to 100 dermatologists","volume":"37","author":"Katz","year":"1997","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0580","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2165\/00128071-200304070-00006","article-title":"The efficacy of calcipotriol+acitretin combination therapy for psoriasis: Comparison with acitretin monotherapy","volume":"4","author":"Rim","year":"2003","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0585","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1177\/120347540400800602","article-title":"The frequent use of oral retinoids in combination with other treatments for psoriasis: A retrospective analysis","volume":"8","author":"Hu","year":"2004","journal-title":"J. Cutan. Med. Surg."},{"key":"10.1016\/j.adengl.2013.01.001_bib0590","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.clindermatol.2003.08.011","article-title":"Changing paradigms in dermatology: Nuclear hormone receptors","volume":"21","author":"Winterfield","year":"2003","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0595","first-page":"82","article-title":"Vitamin D-retinoid association: Molecular basis and clinical applications","volume":"1","author":"Carlberg","year":"1996","journal-title":"J Invest Dermatol Symp Proc"},{"key":"10.1016\/j.adengl.2013.01.001_bib0600","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2340\/0001555559241244","article-title":"Oral retinoid and UVB radiation: A new, alternative treatment for psoriasis on an out-patient basis","volume":"59","author":"Orfanos","year":"1979","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0605","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2133.1984.tb07470.x","article-title":"A randomized double-blind comparison of PUVA-etretinate and PUVA-placebo in the treatment of chronic plaque psoriasis","volume":"110","author":"Parker","year":"1984","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta4400","article-title":"A systematic review of treatments for severe psoriasis","volume":"4","author":"Griffiths","year":"2000","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.adengl.2013.01.001_bib0615","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1067\/mjd.2001.116347","article-title":"Consensus conference: acitretin in combination with UVB or PUVA in the treatment of psoriasis","volume":"45","author":"Lebwohl","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"issue":"Suppl 2","key":"10.1016\/j.adengl.2013.01.001_bib0620","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/jdt.14.s2.17.20","article-title":"Retrospective study of the efficacy of narrowband UVB and acitretin","volume":"14","author":"Spuls","year":"2003","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.adengl.2013.01.001_bib0625","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0190-9622(91)70089-K","article-title":"Acitretin plus UVB therapy for psoriasis: comparisons with placebo plus UVB and acitretin alone","volume":"24","author":"Lowe","year":"1991","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0630","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archderm.1990.01670280066012","article-title":"Efficiency of acitretin in combination with UV-B in the treatment of severe psoriasis","volume":"126","author":"Ruzicka","year":"1990","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0635","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/0190-9622(91)70253-X","article-title":"Photochemotherapy for severe psoriasis without or in combination with acitretin: a randomized, double-blind comparison study","volume":"25","author":"Tanew","year":"1991","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0640","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2340\/00015555-0529","article-title":"A randomized comparison of acitretin-narrow-band TL-01 phototherapy and acitretin-psoralen plus ultraviolet A for psoriasis","volume":"88","author":"Ozdemir","year":"2008","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0645","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.jaad.2009.12.054","article-title":"A review of phototherapy protocols for psoriasis treatment","volume":"64","author":"Lapolla","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0650","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S0190-9622(99)70361-0","article-title":"Acitretin combination therapy","volume":"41","author":"Roenigk","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0655","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0190-9622(84)80007-9","article-title":"Treatment of generalized pustular psoriasis with etretinate (Ro-10-0359) and methotrexate","volume":"10","author":"Rosenbaum","year":"1984","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0660","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/09546630701759579","article-title":"Concurrent use of methotrexate and acitretin revisited","volume":"19","author":"Lowenthal","year":"2008","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.adengl.2013.01.001_bib0665","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0190-9622(09)80147-3","article-title":"Combination of etretinate with cyclosporine in the treatment of severe recalcitrant psoriasis","volume":"30","author":"Brechtel","year":"1994","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0670","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000246070","article-title":"Failure of combination therapy with acitretin and cyclosporin A in 3 patients with erythrodermic psoriasis","volume":"194","author":"Kuijpers","year":"1997","journal-title":"Dermatology"},{"key":"10.1016\/j.adengl.2013.01.001_bib0675","first-page":"177","article-title":"Efficacy of cyclosporine plus etretinate in the treatment of erythrodermic psoriasis (three case reports)","volume":"11","author":"Kokelj","year":"1998","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0680","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jaad.2009.05.048","article-title":"Treatment of erythrodermic psoriasis: From the medical board of the National Psoriasis Foundation","volume":"62","author":"Rosenbach","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0685","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/09546630500482928","article-title":"Novel combination regimens: biologics and acitretin for the treatment of psoriasis\u2014a case series","volume":"17","author":"Conley","year":"2006","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.adengl.2013.01.001_bib0690","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-4632.2008.03470.x","article-title":"Combining systemic retinoids with biologic agents for moderate to severe psoriasis","volume":"47","author":"Smith","year":"2008","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0695","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1610-0387.2012.07976.x","article-title":"Combination of adalimumab with traditional systemic antipsoriatic drugs\u2014a report of 39 cases","volume":"10","author":"Phillipp","year":"2012","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.adengl.2013.01.001_bib0700","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1468-3083.2010.03613.x","article-title":"Combining etanercept with traditional agents in the treatment of psoriasis: A review of the clinical evidence","volume":"24","author":"Foley","year":"2010","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0705","article-title":"Refractory generalized pustular psoriasis responsive to a combination of adalimumab and acitretin","author":"Gallo","year":"2012","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0710","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/S0190-9622(99)70363-4","article-title":"Systemic sequential therapy of psoriasis: A new paradigm for improved therapeutic results","volume":"41","author":"Koo","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0715","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/09546639709160505","article-title":"Current management of psoriasis","volume":"8","author":"Gawkrodger","year":"1997","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.adengl.2013.01.001_bib0720","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0190-9622(96)80148-4","article-title":"Prooceedings of the Psoriasis Combination and Rotation Therapy Conference","volume":"34","author":"Menter","year":"1996","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0725","doi-asserted-by":"crossref","first-page":"47S","DOI":"10.1111\/1523-1747.ep12505769","article-title":"Metabolism of natural retinoids in psoriasis","volume":"95","author":"Siegenthaler","year":"1990","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.adengl.2013.01.001_bib0730","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1096\/fasebj.10.9.8801182","article-title":"Retinoic acid biosynthesis and metabolism","volume":"10","author":"Napoli","year":"1996","journal-title":"FASEB J."}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1578219013001479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1578219013001479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T03:52:18Z","timestamp":1761623538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1578219013001479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":146,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1578219013001479"],"URL":"https:\/\/doi.org\/10.1016\/j.adengl.2013.01.001","relation":{},"ISSN":["1578-2190"],"issn-type":[{"value":"1578-2190","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guidelines for the Use of Acitretin in Psoriasis","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adengl.2013.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2013.01.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Espa\u00f1a, S.L. and AEDV.","name":"copyright","label":"Copyright"}]}}